BiotechTV

𝐖𝐡𝐚𝐫𝐭𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞: Irene Rombel, Co-founder and CEO of BioCurie discuss AI in biotech and keeping manufacturing of advanced therapies in the United States.

@BigChodu @WassimLaroussi3 Always appreciate you, thanks.

@BiotechTV @WassimLaroussi3 Thanks @BiotechTV team..

𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲: The final week of April was a huge week for biopharma M&A. Here's a look back on some of the biggest deals.

𝐖𝐞𝐞𝐤 𝐢𝐧 𝐑𝐞𝐯𝐢𝐞𝐰: The past week in biotech saw companies make big moves in both directions. Here's a summary of the key action. $CUE $MANE $KALV $CMPX $ERAS $SMMT Link to video: biotechtv.com/post/biotech-m…

𝐖𝐡𝐚𝐫𝐭𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞: Airalux Medical is creating a digital breathing device to help patients recover from surgery. Full video: biotechtv.com/post/airalux-m…

𝐂𝐨𝐨𝐥 𝐓𝐞𝐜𝐡: Bay Area based Curve Biosciences is creating a DNA based blood test to detect and measure chronic illness throughout the body - the first programs will focus on liver disease. Full video: biotechtv.com/post/curve-bio…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: Friedrich von Bohlen, Co-Founder & CEO of the data science company @MolecularHealth, has been at the forefront of biotech in Germany since the 1990's. He describes his work and thoughts on the sector. Full video: biotechtv.com/post/friedrich…

𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲: Large pharmaceutical companies are managing unprecedented patent cliffs over the coming years. Here’s what Bristol and Pfizer have been doing to prepare for the upcoming loss of patent protection on the blood thinner Eliquis.

@giger1964 Layoffs are always a sad thing

@BiotechTV Mixed feelings watching this. I was 10y too early in that story, yes, FIH was originally planned in 2016 ! Many reasons, but mostly execution on the CMC front drove $HPHA close to the edge, if it weren't for Dievini/Hoop, which in turn kept other II away... Looking better now.

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: Most ADCs use microtubule inhibitors or DNA-damaging agents at their payload. Heidelberg Pharma believes a greater diversity is needed and has a unique amanitin payload for its programs. Full video: biotechtv.com/post/heidelber…

𝐖𝐡𝐚𝐫𝐭𝐨𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞: Irene Rombel, Co-founder and CEO of BioCurie discuss how AI and companies like AWS And Nvidia have made tangible contributions to clinical trials.

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: FundaMental Pharma aims to develop a dual-acting NMDA receptor modulator for treatment resistant depression to improve on the risk profile seen today with esketamine. Full video: biotechtv.com/post/fundament…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: @KeJahnke is leading research at the Max Planck Institute for Medical Research to better understand cell membranes and lipids. This type of work is vital for improving drug delivery. Full video: biotechtv.com/post/kevin-jah…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: The Head of Research at BioMed X, which was founded in Heidelberg but now does science around the globe, highlights a few key research projects. Full video: biotechtv.com/post/biomed-x-…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: CorTec Neuro's brain-computer interface is designed to both stimulate the brain of those recovering from stroke and do thought based computer control. A patient in Seattle used his mind to play Pong. Full video: biotechtv.com/post/cortec-ne…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: At BioMed X in Heidelberg, scientists Aashritha Ramesh and Clara Romero Garcia showed us a new piece of equipment that prints tumors.

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: CorTec Neuro demonstrated today that its brain computer interface can not only stimulate the brain, but also enable users to control computers with thought. In a new video, a Seattle patient controlled the game Pong. Learn more: biotechtv.com/post/cortec-ne…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: Heidelberg University's Dean of the Faculty of Medicine, Dr. @Michael_Boutros, describes the areas of biomedical research that the university is at the forefront of. Full video: biotechtv.com/post/heidelber…

𝐅𝐫𝐨𝐦 𝐆𝐞𝐫𝐦𝐚𝐧𝐲: Heidelberg University has created a unique platform, hei_INNOVATION, that is meant to encourage its students to become entrepreneurs and then help them achieve their goals along the way. Full video: biotechtv.com/post/hei-innov…

𝐅𝐫𝐨𝐦 𝐇𝐞𝐢𝐝𝐞𝐥𝐛𝐞𝐫𝐠: @BioRNCluster Executive Director Julia Schaft describes the world class science happening in the Rhine-Neckar region today and how they are trying to catalyze more biotech companies out of it. Full video: biotechtv.com/post/biorn-jul…